Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics
Open Access
- 1 July 2018
- journal article
- review article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 128, 337-362
Abstract
No abstract availableKeywords
Funding Information
- European Framework Programme for Research and Innovation Horizon 2020 (721098)
This publication has 209 references indexed in Scilit:
- Nasal drug delivery devices: characteristics and performance in a clinical perspective—a reviewDrug Delivery and Translational Research, 2012
- In silico models of aerosol delivery to the respiratory tract — Development and applicationsAdvanced Drug Delivery Reviews, 2012
- Coarse-Grained Modeling of Mucus Barrier PropertiesBiophysical Journal, 2012
- Trigeminal Pathways Deliver a Low Molecular Weight Drug from the Nose to the Brain and Orofacial StructuresMolecular Pharmaceutics, 2010
- Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate SystemsJournal of Pharmaceutical Sciences, 2009
- Mathematical modeling of molecular diffusion through mucusAdvanced Drug Delivery Reviews, 2009
- Characteristics of compounds that cross the blood-brain barrierBMC Neurology, 2009
- Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative diseaseBMC Neuroscience, 2008
- Nanoparticle size and surface properties determine the protein corona with possible implications for biological impactsProceedings of the National Academy of Sciences of the United States of America, 2008
- Macromolecular Crowding and Confinement: Biochemical, Biophysical, and Potential Physiological ConsequencesAnnual Review of Biophysics, 2008